Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells

Berbamine Enhances the Antineoplastic Activity of Gemcitabine in Pancreatic Cancer Cells by Activating Transforming Growth Factor-β/Smad Signaling

(2014) Xiaoli Jin et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Risk of Pancreatic Adenocarcinoma in Patients With Hereditary Pancreatitis: A National Exhaustive Series

(2013) Vinciane Rebours et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): At the cross-road of pancreatic cancer cell proliferation

(2013) Alessandra Dicitore et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma

(2013) Simon M. Denley et al.   JOURNAL OF GASTROINTESTINAL SURGERY

The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma

(2013) Su-Feng Chen et al.   JOURNAL OF PATHOLOGY

Invasive markers identified by gene expression profiling in pancreatic cancer

(2013) A. Rogers et al.   PANCREATOLOGY

Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation

(2012) Yeon-Sook Choi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells

(2012) Annett Schmieder et al.   CYTOKINE

The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells

(2011) Giovanni Vitale et al.   BIOTECHNOLOGY ADVANCES

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Serum Interleukin-33 Levels in Patients with Gastric Cancer

(2011) Pinghu Sun et al.   DIGESTIVE DISEASES AND SCIENCES

Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1

(2011) Hendrik Ungefroren et al.   Molecular Cancer

Nuclear expression of interleukin-33 in pancreatic stellate cells

(2010) Atsushi Masamune et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cells

(2009) Brian Hutzen et al.   Cancer Cell International

Cucurbitacin B Induces Apoptosis by Inhibition of the JAK/STAT Pathway and Potentiates Antiproliferative Effects of Gemcitabine on Pancreatic Cancer Cells

(2009) N. H. Thoennissen et al.   CANCER RESEARCH

Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis

(2008) Nhu-An Pham et al.   BMC CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor  -Mediated Invasion and Metastasis in Pancreatic Cancer Cells

(2008) S. Zhao et al.   CANCER RESEARCH

Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2

(2008) Kelly J. Gordon et al.   CARCINOGENESIS

Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket

(2008) Lucie Roussel et al.   EMBO REPORTS

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

(2008) S. Jones et al.   SCIENCE